Researchers at the BC Cancer Agency discover a significant connection between the spread of breast cancer and a natural enzyme, called CA9. This discovery proves CA9 is a major target in tumour survival and growth in over 50 per cent of the deadliest forms of breast cancer and 16 per cent of all breast cancers – researchers can now halt the spread of these tumours through the use of novel drugs.